TABLE 2—
Baseline Characteristics Between Housing Consumers Living With HIV and Control Group Persons Living With HIV by Enrollment Length: New York City, 2013–2017
| Long-Terma Consumers, No. (%) | Controls, No. (%) | P | Short-Terma Consumers, No. (%) | Controls, No. (%) | P | |
| All | 269 (100) | 538 (100) | . . . | 292 (100) | 584 (100) | . . . |
| Demographic characteristics | ||||||
| Genderb | .82 | .9 | ||||
| Cisgender man | 179 (66.5) | 362 (67.3) | 188 (64.4) | 383 (65.6) | ||
| Cisgender woman | 85 (31.6) | 169 (31.4) | 98 (33.6) | 191 (32.7) | ||
| Transgender woman | 5 (1.9) | 7 (1.3) | 6 (2.1) | 10 (1.7) | ||
| Race/ethnicity | > .99 | > .99 | ||||
| Non-Hispanic Black | 126 (46.8) | 252 (46.8) | 167 (57.2) | 333 (57.0) | ||
| Hispanic | 132 (49.1) | 264 (49.1) | 108 (37) | 217 (37.2) | ||
| Non-Hispanic White | 8 (3.0) | 16 (3.0) | 15 (5.1) | 30 (5.1) | ||
| Asian/Pacific Islander | 2 (0.7) | 4 (0.7) | 2 (0.7) | 4 (0.7) | ||
| Multiracial | 1 (0.4) | 2 (0.4) | 0 (0) | 0 (0) | ||
| Age category, y | > .99 | > .99 | ||||
| 18–24 | 12 (4.5) | 24 (4.5) | 17 (5.8) | 33 (5.7) | ||
| 25–44 | 107 (39.8) | 214 (39.8) | 118 (40.4) | 236 (40.4) | ||
| 45–64 | 142 (52.8) | 284 (52.8) | 149 (51.0) | 299 (51.2) | ||
| ≥ 65 | 8 (3.0) | 16 (3.0) | 8 (2.7) | 16 (2.7) | ||
| Birth country | > .99 | > .99 | ||||
| United States | 115 (42.8) | 237 (44.1) | 174 (59.6) | 353 (60.4) | ||
| US dependency | 19 (7.1) | 37 (6.9) | 25 (8.6) | 45 (7.7) | ||
| Foreign country | 118 (43.9) | 230 (42.8) | 71 (24.3) | 142 (24.3) | ||
| Unknown | 17 (6.3) | 34 (6.3) | 22 (7.5) | 44 (7.5) | ||
| HIV-related medical characteristics | ||||||
| Baseline engagement in carec | .48 | .06 | ||||
| No | 4 (1.5) | 12 (2.2) | 3 (1.0) | 18 (3.1) | ||
| Yes | 265 (98.5) | 526 (97.8) | 289 (99.0) | 566 (96.9) | ||
| Baseline viral suppressiond | .77 | .45 | ||||
| No | 59 (21.9) | 123 (22.9) | 74 (25.3) | 162 (27.7) | ||
| Yes | 210 (78.1) | 415 (77.1) | 218 (74.7) | 422 (72.3) | ||
| Baseline CD4 count category (cells/mm3)e | .84 | .69 | ||||
| Missing | 6 (2.2) | 18 (3.3) | 7 (2.4) | 23 (3.9) | ||
| < 200 | 28 (10.4) | 53 (9.9) | 41 (14.0) | 82 (14.0) | ||
| 200–499 | 92 (34.2) | 180 (33.5) | 110 (37.7) | 211 (36.1) | ||
| ≥ 500 | 143 (53.2) | 287 (53.3) | 134 (45.9) | 268 (45.9) | ||
Note. Controls were sampled 2:1 from the New York City HIV surveillance registry and matched to individual Housing Opportunities for Persons With AIDS consumers on clinical and demographic characteristics.
Long-term consumers were consumers who were enrolled for no less than 1 year, and short-term consumers were consumers who were enrolled for less than 1 year.
Persons not known to be transgender were classified as cisgender (i.e., not transgender).
Baseline engagement in care was defined as having at least 1 VL or CD4 count within 12 mo before the enrollment month.
Baseline viral suppression was defined as the last quantitative viral load within 12 mo before the enrollment month was ≤ 200 copies/mL.
Baseline CD4 count category was based on the last CD4 count within 12 mo before the enrollment month.